quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
hematopoietic stem cell transplantation	566
of conflict of interest	479
disclosure of conflict of	479
at the time of	322
allogeneic stem cell transplantation	321
in the presence of	313
allogeneic hematopoietic stem cell	304
of this study was	301
the aim of this	293
this study was to	286
aim of this study	261
as well as the	229
graft versus host disease	228
aim of the study	206
in the absence of	194
autologous stem cell transplantation	173
cd and cd t	165
severe acute respiratory syndrome	164
in the context of	163
with a median follow	153
peripheral blood stem cells	137
on the other hand	134
was found to be	134
is one of the	134
median age was years	129
has been shown to	129
peripheral blood stem cell	129
in the treatment of	128
an important role in	127
for the treatment of	126
a total of patients	126
at a median of	116
of this study is	114
specific cd t cells	112
this study is to	109
of cd t cells	105
haematopoietic stem cell transplantation	104
cd t cell epitopes	103
at the end of	102
in the number of	101
and cd t cells	101
the total number of	101
stem cell transplantation in	101
the cumulative incidence of	101
as a result of	100
for the development of	100
for the detection of	99
on the surface of	98
on the basis of	97
were included in the	97
in the setting of	96
a median of days	95
one of the most	94
the aim of the	94
a median age of	93
study was to evaluate	93
cd t cell responses	92
in the development of	92
median follow up of	92
in the case of	92
in the pathogenesis of	91
after allogeneic stem cell	90
in this study we	90
been shown to be	90
have been shown to	87
no significant difference in	85
to be associated with	85
the median age was	85
mhc class i molecules	84
there was no significant	84
with a median age	84
of the immune system	84
a median follow up	83
was to evaluate the	82
peripheral blood mononuclear cells	82
as well as in	82
after allogeneic hematopoietic stem	82
at the same time	81
the purpose of this	81
there was no difference	81
was significantly higher in	81
acute and chronic gvhd	80
play a role in	80
p disclosure of conflict	80
allogeneic hematopoietic cell transplantation	80
the end of the	79
t cells in the	78
in the present study	76
play an important role	75
for the first time	75
can be used to	74
were found to be	74
to the development of	74
between the two groups	74
the median time to	73
after a median follow	73
for the presence of	73
these data suggest that	73
of the study was	72
major histocompatibility complex class	72
of cd and cd	72
these results suggest that	72
was no significant difference	71
the objective of this	71
in vitro and in	70
was associated with a	70
the majority of patients	70
blood stem cell transplantation	70
cumulative incidence of relapse	70
purpose of this study	70
the results of the	70
is associated with a	69
cd t cells in	69
a median time of	69
there were no significant	68
the median number of	68
stem cell transplantation for	68
nothing to declare background	68
blood and blood products	67
of blood and blood	66
of mhc class i	66
reduce the risk of	65
included in the study	65
acute respiratory syndrome coronavirus	64
the mhc class i	64
the presence of a	63
vitro and in vivo	63
important role in the	63
objective of this study	63
of hla class i	62
median age of years	62
we were able to	62
cd t cells were	61
the study was to	60
studies are needed to	60
memory cd t cells	60
of the immune response	60
has granted medrxiv a	59
who has granted medrxiv	59
is the author funder	59
granted medrxiv a license	59
display the preprint in	59
to display the preprint	59
license to display the	59
the preprint in perpetuity	59
medrxiv a license to	59
a license to display	59
with the use of	58
source of stem cells	58
and the number of	58
safety and efficacy of	58
acute graft versus host	58
is the most common	58
in the control group	57
class i and class	57
of red blood cells	57
and cd t cell	56
the median age at	56
class i and ii	56
studies have shown that	56
this is the first	56
it is possible to	56
of cd t cell	56
in the majority of	56
of our study was	55
number of cd cells	55
hematopoietic stem cell transplant	55
the aim of our	55
it is important to	55
presence or absence of	54
the use of the	54
a large number of	54
patients were treated with	54
the role of the	53
has been associated with	53
median time to neutrophil	53
copyright holder for this	52
there were no differences	52
study was to determine	52
our data suggest that	52
is based on the	52
for this preprint this	52
this preprint this version	52
was significantly lower in	52
stem cell source was	52
were no significant differences	52
the copyright holder for	52
in the united states	52
preprint this version posted	52
holder for this preprint	52
was to assess the	52
in the group of	52
nothing to declare p	52
of mhc class ii	52
t cell responses to	51
the median age of	51
no significant differences in	51
the number of cd	51
an increase in the	51
in addition to the	51
i and class ii	51
cd t cells and	50
during the study period	50
as part of the	50
the quality of the	50
blood and blood components	50
was no difference in	50
on the cell surface	49
were more likely to	49
histocompatibility complex class i	49
are shown in table	49
the development of a	49
of the patients with	49
neutrophil and platelet engraftment	49
the majority of the	49
may be due to	49
as well as a	48
aim of our study	48
in of the patients	48
an increased risk of	48
on the day of	48
of red blood cell	48
it has been shown	48
our study was to	48
little is known about	48
may be associated with	47
the presence of the	47
of allogeneic hematopoietic stem	47
autologous hematopoietic stem cell	47
of morbidity and mortality	47
were included in this	47
cells as well as	47
allogeneic haematopoietic stem cell	47
was observed in patients	46
significant difference in the	46
mhc class ii molecules	46
to reduce the risk	46
in the regulation of	46
at a dose of	46
center background case studies	46
a significant increase in	46
during the course of	46
increase in the number	46
in a patient with	45
in patients with severe	45
the incidence of acute	45
none of the patients	45
patients with multiple myeloma	45
a retrospective analysis of	45
the expression of the	45
of the t cell	45
mhc class i and	45
cd t cells from	44
with the exception of	44
in a cohort of	44
and the use of	44
at a median follow	44
were significantly higher in	44
of severe acute respiratory	44
stem cell transplantation is	44
study was to investigate	44
our results show that	44
efficacy and safety of	43
our results suggest that	43
total of patients were	43
in the course of	43
that the use of	43
there was a significant	43
in the last years	43
human immunodeficiency virus type	43
both cd and cd	42
the safety and efficacy	42
the conditioning regimen was	42
hla class i and	42
has the potential to	42
the median duration of	42
and the presence of	42
in the peripheral blood	42
transplantation in patients with	41
incidence of acute gvhd	41
was significantly associated with	41
the specificity of the	41
with a history of	41
associated with an increased	41
morbidity and mortality in	41
the presence or absence	41
was not associated with	41
the immune response to	41
it was found that	41
was performed using the	41
of the patients who	40
had no effect on	40
been found to be	40
c e l l	40
significantly higher in the	40
of acute and chronic	40
the outcome of patients	40
as well as to	40
acute or chronic gvhd	40
conditioning regimen consisted of	40
the major histocompatibility complex	39
a role in the	39
specific cd t cell	39
gvhd prophylaxis consisted of	39
the cd t cell	39
the central nervous system	39
has been shown that	39
over a period of	39
the t cell receptor	39
in the field of	39
follow up of months	39
hla class i molecules	39
university school of medicine	39
in patients who received	39
we performed a retrospective	39
with a median of	39
time from diagnosis to	39
of the use of	39
r n a l	39
was to investigate the	38
these results indicate that	38
did not differ between	38
with acute myeloid leukemia	38
on the use of	38
year cumulative incidence of	38
we found that the	37
in the production of	37
has been reported to	37
u r n a	37
the vast majority of	37
study was to assess	37
o u r n	37
plays an important role	37
no statistically significant difference	37
j o u r	37
p r o o	37
r o o f	37
cd t cell response	37
n a l p	37
haploidentical stem cell transplantation	37
to be involved in	37
age at transplant was	37
a l p r	37
as compared to the	37
l p r e	37
in the management of	36
scansystem tm platelet kit	36
in contrast to the	36
ifitm ifitm double null	36
at the age of	36
after hematopoietic stem cell	36
the goal of this	36
it is known that	36
with the development of	36
the implementation of the	36
autologous peripheral blood stem	36
of the patients were	36
have been associated with	36
included in this study	36
a wide range of	36
cd t cell epitope	35
option for patients with	35
in accordance with the	35
has been found to	35
cause of morbidity and	35
a risk factor for	35
and the development of	35
patients who did not	35
the surface of the	35
are summarized in table	35
causes of death were	35
innate and adaptive immune	35
chronic graft versus host	35
treatment of patients with	35
was used as a	35
by the presence of	35
in patients treated with	35
in order to evaluate	35
under a is the	34
were no differences in	34
the performance of the	34
that the number of	34
is made available under	34
in the form of	34
a major cause of	34
study was to analyze	34
acute gvhd grade ii	34
a is the author	34
license it is made	34
available under a is	34
international license it is	34
the presence of anti	34
in order to prevent	34
it is made available	34
made available under a	34
in the induction of	34
the impact of the	34
a significant proportion of	34
reduced intensity conditioning regimen	34
hemolytic disease of the	34
patients with high risk	34
study is to evaluate	33
the quality of blood	33
there was a trend	33
of the patients was	33
median age at transplant	33
for up to days	33
allogeneic stem cell transplant	33
of the study is	33
patients with hematological malignancies	33
in the first days	33
most common cause of	33
on the outcome of	33
in the serum of	33
t cells specific for	33
after a median of	33
we have developed a	33
the expression of cd	33
the course of the	33
was to determine the	33
by the use of	33
is the only curative	33
with the presence of	33
in the diagnosis of	33
the main cause of	33
was detected in the	33
in the bone marrow	32
we have shown that	32
was significantly higher than	32
as well as for	32
the time of the	32
in the general population	32
of the patients had	32
t cell response to	32
the use of a	32
with a median time	32
patients were included in	32
median age of the	32
are involved in the	32
the innate immune system	32
compared to patients with	32
that there is a	32
our aim was to	32
the most common cause	32
in the blood bank	32
between january and december	32
patients with acute myeloid	32
we conducted a retrospective	32
in critically ill patients	32
in the process of	32
by flow cytometry and	32
in comparison to the	32
at a median time	32
of allogeneic stem cell	32
in the two groups	31
was defined as the	31
the stem cell source	31
of the patients received	31
no conflict of interest	31
to the number of	31
of patients who received	31
in order to determine	31
allogeneic bone marrow transplantation	31
be involved in the	31
a decrease in the	31
in patients with aml	31
is associated with the	31
for the generation of	31
this work was supported	31
a higher risk of	31
it was shown that	31
in relation to the	31
test was used to	31
be used as a	31
in out of patients	31
median time of days	31
which was not certified	30
no significant difference was	30
analyzed by flow cytometry	30
results suggest that the	30
at the beginning of	30
not certified by peer	30
these data indicate that	30
is known about the	30
for the prevention of	30
therapy in patients with	30
of the conditioning regimen	30
been reported to be	30
mhc class i binding	30
use of blood components	30
was not certified by	30
and toxic epidermal necrolysis	30
t cell responses in	30
evaluate the impact of	30
used in this study	30
cd t cells with	30
certified by peer review	30
in an attempt to	30
was not statistically significant	30
may contribute to the	30
have been reported to	30
t h a t	30
one of the major	30
shown in the table	30
for each of the	30
the activation of the	30
x cd cells kg	30
from january to december	30
study was to compare	29
of the fetus and	29
was found in the	29
was not significantly different	29
is involved in the	29
this version posted october	29
t i o n	29
incidence of chronic gvhd	29
a significant reduction of	29
disease of the newborn	29
in the control of	29
patients with a median	29
outcome of patients with	29
and autologous stem cell	29
of hematopoietic stem cells	29
these results demonstrate that	29
the mean number of	29
have been used to	29
work was supported by	29
it has been reported	29
in patients with acute	29
similar in both groups	29
the safety of blood	29
of hematopoietic stem cell	29
in the immune response	29
a matched unrelated donor	28
no significant difference between	28
age of the patients	28
with respect to the	28
conditioning regimen was myeloablative	28
for the diagnosis of	28
can be used as	28
was observed in the	28
when compared to the	28
the effect of the	28
in the first months	28
the efficacy of the	28
before and after the	28
with severe acute respiratory	28
we conclude that the	28
significant differences in the	28
with sickle cell disease	28
of hla class ii	28
bone marrow transplantation in	28
related acute lung injury	28
role in the pathogenesis	28
or more of the	28
to the lack of	28
of the mhc class	28
the basis of the	28
to be able to	28
a critical role in	28
as a source of	28
and total body irradiation	28
a significant difference in	28
vg vd t cells	28
to the presence of	28
the size of the	27
it is necessary to	27
in the multivariate analysis	27
for the identification of	27
was the most common	27
significant difference between the	27
source was peripheral blood	27
a limited number of	27
the median time from	27
for the use of	27
due to the lack	27
most of the patients	27
goal of this study	27
statistical analysis was performed	27
to better understand the	27
of cd cells in	27
is known to be	27
data suggest that the	27
of the present study	27
with an increased risk	27
the world health organization	27
the time of transplant	27
be due to the	27
is to evaluate the	27
by the addition of	27
the average number of	27
the presence of hla	27
blood samples were collected	27
in any of the	27
is due to the	27
we have previously shown	27
the mhc class ii	27
after stem cell transplantation	27
to neutrophil and platelet	27
the severity of the	27
umbilical cord blood transplantation	27
during the first year	27
blood and marrow transplantation	27
for the production of	26
as shown in table	26
or in combination with	26
is thought to be	26
this is a retrospective	26
the median time of	26
this study aimed to	26
has been used to	26
the analysis of the	26
the identification of the	26
blood transfusion service in	26
median age of patients	26
the number of patients	26
were positive for anti	26
in order to identify	26
in lung transplant recipients	26
a member of the	26
blood banking and transfusion	26
as an alternative to	26
syndrome and toxic epidermal	26
a significant reduction in	26
at least one of	26
patients with and without	26
treatment for patients with	26
the safety of the	26
high density multiepitope protein	26
for their ability to	26
the study is to	26
of patients who underwent	26
johnson syndrome and toxic	26
t and b cells	26
the only curative treatment	26
to evaluate the impact	26
to the use of	26
the efficacy and safety	26
t cell epitope discovery	26
patients with acute leukemia	26
for the induction of	26
haemolytic disease of the	26
at high risk of	26
not significantly different between	26
the present study was	26
in order to improve	26
were not significantly different	26
the treatment of patients	26
a better understanding of	26
a high rate of	26
has been reported in	26
in pediatric patients with	25
for the determination of	25
in this retrospective study	25
n and h n	25
at different time points	25
the absence of a	25
may play a role	25
of umbilical cord blood	25
dose of mg kg	25
on the number of	25
in patients with a	25
did not differ significantly	25
the aim was to	25
as shown in fig	25
cause of death in	25
the case of a	25
to ensure that the	25
those who did not	25
a crucial role in	25
were associated with a	25
investigate the role of	25
in the group with	25
a cohort of patients	25
analysis was performed using	25
results indicate that the	25
significant differences between the	25
study was designed to	25
is the most important	25
are the most common	25
the beginning of the	25
no significant differences between	25
was determined to be	25
it has been suggested	25
a wide variety of	25
it is clear that	25
as a function of	25
the difference between the	24
to the risk of	24
has been suggested that	24
in vivo and in	24
we retrospectively analyzed the	24
disease of the fetus	24
the control of the	24
of the patient and	24
the development of the	24
a higher incidence of	24
patient and graft survival	24
associated with increased risk	24
were enrolled in the	24
this group of patients	24
differences between the two	24
the risk of transfusion	24
has been observed in	24
our results indicate that	24
used to determine the	24
in the presence or	24
a high incidence of	24
these findings suggest that	24
in the activation of	24
a key role in	24
a major role in	24
the intensive care unit	24
a reduced intensity conditioning	24
the age of years	24
the ability of the	24
of patients with a	24
stem cell transplantation from	24
of blood components and	24
specific cytotoxic t lymphocytes	24
the results of this	24
patients who received a	24
cells in response to	24
a high level of	24
had at least one	24
in patients with multiple	24
cd t cells are	24
the first year after	24
could be used to	24
of peripheral blood stem	24
no significant differences were	23
hla class i alleles	23
were excluded from the	23
of blood components is	23
w i t h	23
a safe and effective	23
e l l s	23
the quality of life	23
packed red blood cells	23
was not detected in	23
one of the main	23
stored at room temperature	23
more likely to be	23
there is a need	23
received peripheral blood stem	23
does not seem to	23
antigen processing and presentation	23
reducing the risk of	23
median age at hsct	23
further studies are needed	23
a broad spectrum of	23
patients were divided into	23
t and b cell	23
were detected in cases	23
samples were tested for	23
a significant decrease in	23
in a multivariate analysis	23
of acute gvhd grade	23
significant difference was found	23
associated with antigen processing	23
there is no significant	23
reduces the risk of	23
specific cd and cd	23
were obtained from the	23
probably due to the	23
age of patients was	23
survival in patients with	23
at the site of	23
ifitm double null cells	23
medical center background case	23
a small number of	23
there was no statistical	23
cell transplantation in patients	23
to an increase in	23
proportion of patients with	23
patients died due to	23
can be used for	23
of major histocompatibility complex	23
in allogeneic stem cell	23
associated with a high	23
morbidity and mortality after	23
to be the most	23
as a consequence of	23
the council of europe	23
in line with the	23
have previously shown that	23
the indirect antiglobulin test	23
found to be positive	23
well as in the	23
the presence of an	23
was shown to be	23
determined by flow cytometry	23
the mean age of	23
a high risk of	23
was to analyze the	23
in more than of	23
the first days after	23
with increased risk of	23
by cd t cells	23
the immune epitope database	22
expression of cd and	22
of patients treated with	22
is associated with increased	22
the red blood cells	22
red blood cells and	22
this study aims to	22
were in complete remission	22
are more likely to	22
alone or in combination	22
in patients with high	22
least one of the	22
associated with a higher	22
followed by autologous stem	22
there was no statistically	22
has been reported that	22
at the cell surface	22
median time from diagnosis	22
a high degree of	22
with an increase in	22
t cell epitopes from	22
has led to the	22
on behalf of the	22
dna was extracted from	22
median age at transplantation	22
in spite of the	22
may be involved in	22
in the era of	22
of fresh frozen plasma	22
have the potential to	22
group and in the	22
compared to those with	22
engraftment was achieved in	22
was performed in the	22
a final concentration of	22
we did not observe	22
in first complete remission	22
the adaptive immune system	22
cumulative incidence of grade	22
no difference in the	22
half of the patients	22
patients with sickle cell	22
the risk of relapse	22
source was bone marrow	22
weak d type was	22
we did not find	22
a pivotal role in	22
was significantly lower than	22
the fetus and newborn	22
but not in the	22
incidence of grade ii	22
in the gvh direction	22
of systemic lupus erythematosus	22
to cd t cells	22
more likely to have	22
antibodies were detected in	22
median follow up was	22
the mhc i hla	22
our data show that	22
national institutes of health	22
incidence and severity of	22
the molecular basis of	22
to the cell surface	22
high morbidity and mortality	22
middle east respiratory syndrome	22
by flow cytometry using	22
of patients in the	21
was associated with increased	21
of the most important	21
report a case of	21
the patients who received	21
a total of samples	21
are shown in the	21
with the aim to	21
with the median being	21
a result of the	21
based on these results	21
the proportion of patients	21
and quality of life	21
the introduction of the	21
a matched related donor	21
included in the analysis	21
histocompatibility complex class ii	21
eosinophilia and systemic symptoms	21
did not affect the	21
dose chemotherapy followed by	21
iv acute gvhd was	21
compared to that of	21
was no difference between	21
of human immunodeficiency virus	21
was carried out using	21
during the period of	21
the peripheral blood of	21
were observed in the	21
area under the curve	21
did not correlate with	21
with systemic lupus erythematosus	21
a n t i	21
we report a case	21
on the development of	21
time to neutrophil and	21
of regulatory t cells	21
as stem cell source	21
for the management of	21
enrolled in the study	21
transporter associated with antigen	21
had a history of	21
of the cd t	21
to be related to	21
the standard of care	21
the frequency of the	21
of t cell activation	21
was performed on the	21
and is associated with	21
vivo and in vitro	21
to investigate the role	21
was used for the	21
of t cell responses	21
results show that the	21
was no statistically significant	21
is no significant difference	21
increases the risk of	21
the most commonly used	21
has not yet been	21
cd cells in the	21
acute respiratory distress syndrome	21
was peripheral blood in	21
of chronic gvhd was	21
of the blood transfusion	21
the prevalence of the	21
was the most frequent	21
as a marker of	21
on the presence of	21
by autologous stem cell	21
similar to that of	21
in cd t cells	21
should be considered for	21
specific t cell responses	21
the major cause of	21
were detected in the	21
after autologous stem cell	21
mhc class i molecule	21
a group of patients	21
of minimal residual disease	21
the rest of the	21
of t cell receptor	21
the sensitivity of the	21
median age at diagnosis	21
of hbv infection in	21
to determine if the	21
to the fact that	21
be considered as a	21
memory cd t cell	21
as the number of	20
were used to determine	20
a dose of mg	20
cell epitopes of the	20
in adult patients with	20
in view of the	20
was used to determine	20
in the t cell	20
time to neutrophil engraftment	20
increase the risk of	20
of blood transfusion services	20
patients were transplanted in	20
quality and safety of	20
age at hsct was	20
in response to the	20
allogenic hematopoietic stem cell	20
were added to the	20
in the proportion of	20
we observed that the	20
were significantly lower in	20
due to the high	20
was detected in patients	20
for acute myeloid leukemia	20
to evaluate the efficacy	20
is considered to be	20
is associated with an	20
the time of hsct	20
patients included in the	20
be related to the	20
age at transplantation was	20
in order to provide	20
course of the disease	20
from an unrelated donor	20
to be safe and	20
an integral part of	20
significantly lower in the	20
was to compare the	20
involved in the pathogenesis	20
of whole blood and	20
for hematopoietic stem cell	20
the study of the	20
the binding affinity of	20
a significant number of	20
was found to have	20
with eosinophilia and systemic	20
after bone marrow transplantation	20
there is a significant	20
the hiv infected cells	20
h n and h	20
of the innate immune	20
a median number of	20
human papillomavirus type e	20
better understanding of the	20
one of the two	20
dose chemotherapy and autologous	20
have been found to	20
the group of patients	20
that the majority of	20
the purpose of the	20
to investigate the effect	20
at room temperature for	20
cd t cells to	20
quality of life of	20
in an effort to	20
the first time that	20
within the first days	20
of blood products is	20
in most of the	20
was similar in both	20
the time of transplantation	20
was associated with an	20
for patients with high	20
of blood donation and	20
the expression of hla	20
did not receive any	20
and mhc class ii	20
study is to determine	20
may lead to the	20
did not show any	20
neutrophil and platelet recovery	20
and the expression of	20
the stability of the	20
for a median of	20
of the most common	20
in the early phase	20
is essential for the	20
have been reported in	20
sensitivity and specificity of	20
of peptide binding to	20
haploidentical hematopoietic stem cell	19
positive direct antiglobulin test	19
the last few years	19
was added to the	19
were tested for their	19
blood center background case	19
significant increase in the	19
cells in patients with	19
group of patients with	19
and adaptive immune responses	19
at transplant was years	19
in balb c mice	19
was used in patients	19
contamination of blood products	19
the fact that the	19
specific t cell clones	19
a matched sibling donor	19
received a myeloablative conditioning	19
be used for the	19
macrophages and dendritic cells	19
significant differences were observed	19
to determine whether the	19
cd t cells was	19
was associated with the	19
a median of months	19
the activity of the	19
the clinical course of	19
t cell epitopes and	19
were significantly associated with	19
and the level of	19
innate and adaptive immunity	19
after the onset of	19
the results showed that	19
the length of the	19
the primary endpoint was	19
a central role in	19
epitopes of the sars	19
with an average of	19
was no statistical difference	19
the majority of cases	19
may be related to	19
from the peripheral blood	19
autologous stem cell transplant	19
in the first year	19
were found in the	19
were males and females	19
could be due to	19
out of patients with	19
this study shows that	19
increase the number of	19
in the generation of	19
after the introduction of	19
the characteristics of the	19
in patients who had	19
although the number of	19
of our study is	19
red blood cell transfusion	19
with the addition of	19
data indicate that the	19
that the presence of	19
of the patients in	19
risk factors associated with	19
in the expression of	19
in a mouse model	19
in children and adolescents	19
one or more of	19
t cell activation and	19
was approved by the	19
and the risk of	19
with the amino acids	19
for the preparation of	19
patients with relapsed refractory	19
median time to platelet	19
until the end of	19
were identified in the	19
which is associated with	19
preoperative autologous blood donation	19
in a child with	19
hsct in our center	19
of graft versus host	19
large b cell lymphoma	19
the median follow up	19
the high frequency of	19
a single center experience	19
cell source was peripheral	19
we have found that	19
mobilized peripheral blood stem	19
in comparison with the	19
was performed in patients	19
the initiation of the	19
of the blood donors	19
the authors declare no	19
the t cell response	19
these data show that	18
incidence of relapse was	18
the majority of these	18
for a number of	18
the incidence and severity	18
of the disease and	18
to the type of	18
over the last years	18
no differences in the	18
did not reach statistical	18
are needed to confirm	18
performed according to the	18
cd and cd cells	18
patients with hematologic malignancies	18
a higher number of	18
and t cell epitopes	18
the duration of the	18
diffuse large b cell	18
abo blood group system	18
to the pathogenesis of	18
to evaluate the effectiveness	18
these data demonstrate that	18
of stem cells was	18
a retrospective review of	18
bonds with the amino	18
in children and adults	18
in patients undergoing allogeneic	18
bone marrow transplantation for	18
of cd cd cd	18
in order to reduce	18
incidence of acute rejection	18
hsct in patients with	18
no conflicts of interest	18
stem cell transplantation with	18
in a subset of	18
and bone marrow transplantation	18
expressed on the surface	18
patients with aml in	18
in patients suffering from	18
higher than that of	18
plays a role in	18
with autologous stem cell	18
a reduction in the	18
seems to be a	18
patients who had undergone	18
management of patients with	18
with the number of	18
was bone marrow in	18
study was to examine	18
after reduced intensity conditioning	18
by the blood bank	18
the fi eld of	18
bacterial contamination of blood	18
all patients received a	18
cells in the presence	18
igg molecules per rbc	18
a positive correlation between	18
within the first year	18
by the fact that	18
cell free fetal dna	18
in the first step	18
matched related or unrelated	18
and platelet engraftment was	18
the impact of this	18
number of blood donors	18
of the s protein	18
cd cd t cells	18
the overall response rate	18
investigated the role of	18
gvhd was observed in	18
the conditioning regimen consisted	18
at the university hospital	18
due to the presence	18
mhc class ii binding	18
the source of stem	18
are summarized in the	18
the percentage of cd	18
patients who underwent allo	18
optimised scansystem tm platelet	18
after allogeneic haematopoietic stem	18
the number of blood	18
and in patients with	18
in the united kingdom	18
blood and its components	18
it is possible that	18
at high risk for	18
cells in the graft	18
of gd t cells	18
the patients in the	18
in up to of	18
for the purpose of	18
the only curative option	18
the number of igg	18
the intensity of the	18
after allogeneic hematopoietic cell	18
of the presence of	18
weak d type and	18
at the moment of	18
in patients who have	18
of the rhd gene	18
specific t cells in	18
investigate the effect of	18
were similar in both	18
was higher in the	18
blood components and blood	18
was identified in the	18
a retrospective study of	18
were performed according to	18
excluded from the analysis	18
are likely to be	18
the severe acute respiratory	18
associated with a lower	18
more than of the	17
cohort of patients with	17
no statistically significant differences	17
the blood transfusion service	17
in patients who underwent	17
be one of the	17
not reach statistical significance	17
on the quality of	17
patients with r r	17
hospital background case studies	17
at least in part	17
cd t cells by	17
have an impact on	17
of this retrospective study	17
the highest binding affinity	17
the objective of the	17
cytotoxic t lymphocyte responses	17
study was carried out	17
by mhc class i	17
received a median of	17
regimen was myeloablative in	17
in the use of	17
in order to be	17
have shown that the	17
a high proportion of	17
as part of a	17
was carried out in	17
in patients with chronic	17
hepatitis b surface antigen	17
of this study were	17
above years of age	17
of the number of	17
from diagnosis to transplant	17
with a panel of	17
was found between the	17
between donor and recipient	17
has been implicated in	17
quality of blood products	17
acute and chronic graft	17
in the design of	17
r a n s	17
we investigated the role	17
the absence of the	17
patients who underwent allogeneic	17
of acute or chronic	17
the current study was	17
main cause of death	17
for red blood cell	17
and there was no	17
that the incidence of	17
and all of them	17
in the current study	17
was observed in all	17
analysis was performed by	17
screening of blood donors	17
included in this analysis	17
on the th day	17
standard of care for	17
patient was treated with	17
of cd cells was	17
at the last follow	17
delayed hemolytic transfusion reactions	17
investigated the effect of	17
can be used in	17
was used to assess	17
the incidence of chronic	17
samples were collected from	17
autologous haematopoietic stem cell	17
it is likely that	17
a positive antibody screen	17
nk cells in the	17
from the same donor	17
not differ between the	17
used to evaluate the	17
t r a n	17
this study was designed	17
has not been established	17
to determine the frequency	17
did not lead to	17
tacrolimus and mycophenolate mofetil	17
for a total of	17
this study we have	17
of total body irradiation	17
were found to have	17
of blood transfusion service	17
and weak d type	17
complication of allogeneic hematopoietic	17
of patients were included	17
was used as the	17
patients are alive and	17
is a frequent complication	17
the host immune response	17
the overall incidence of	17
the presence of il	17
we hypothesized that the	17
and disease free survival	17
summarized in the table	17
of the donor and	17
in a number of	17
with the risk of	17
small number of patients	17
banking and transfusion medicine	17
in the frequency of	17
blood donation in the	17
objective of the study	17
of the impact of	17
diagnosis and management of	17
to a lesser extent	17
statistically significant difference between	17
we have observed that	17
will be necessary to	17
the national blood transfusion	17
with severe aplastic anemia	17
studies have demonstrated that	17
is a risk factor	17
a single amino acid	17
red cross blood service	16
the cause of the	16
patients were positive for	16
divided into two groups	16
with the aim of	16
h n influenza virus	16
in this group of	16
human mhc class i	16
to the blood bank	16
were performed in the	16
use of blood and	16
at time of transplant	16
has been described in	16
appears to be a	16
the high incidence of	16
age at diagnosis was	16
for the prediction of	16
and progression free survival	16
at the start of	16
the most common causes	16
by the end of	16
is a prerequisite for	16
found to be associated	16
patients with relapsed or	16
in the incidence of	16
binding affinity to the	16
increased susceptibility to infections	16
patients were transplanted from	16
is to determine the	16
since the introduction of	16
revealed the presence of	16
were compared to the	16
were found in patients	16
compared to patients without	16
not seem to be	16
analyses were performed using	16
we report the results	16
that can be used	16
the outcome of the	16
patients were conditioned with	16
blood and bone marrow	16
t c e l	16
in order to investigate	16
our data indicate that	16
in a variety of	16
of alloreactive t cells	16
in order to avoid	16
of blood and its	16
should be considered as	16
of a variety of	16
t cells from the	16
time to neutrophil recovery	16
we have demonstrated that	16
due to the fact	16
and the need for	16
we report our experience	16
balb c mice were	16
t cells can be	16
peptide binding to mhc	16
for patients with a	16
a large cohort of	16
of the disease in	16
has been developed to	16
are presented in table	16
in the period from	16
was used to identify	16
department of transfusion medicine	16
in a series of	16
class ii antigen presentation	16
therapy for patients with	16
over the course of	16
to determine the incidence	16
the risk factors for	16
no effect on the	16
the entire cohort was	16
were taken from the	16
in the prevention of	16
class i molecules and	16
in order to obtain	16
interval from diagnosis to	16
significantly higher in patients	16
as well as with	16
is consistent with the	16
less than of the	16
for mhc class i	16
is a major cause	16
to be effective in	16
was supported by the	16
outcomes in patients with	16
of the efficacy of	16
hematopoetic stem cell transplantation	16
between the number of	16
with median age of	16
the first months of	16
are known to be	16
for the majority of	16
at the onset of	16
was used to evaluate	16
majority of patients with	16
was based on the	16
here we show that	16
transplantation for patients with	16
reported to the ebmt	16
analysis was performed on	16
and bone marrow in	16
involved in the regulation	16
and the percentage of	16
with a high risk	16
who were treated with	16
number of cd t	16
had a significantly higher	16
the last two years	16
for the entire cohort	16
report the results of	16
a mouse model of	16
in all the patients	16
overall survival at years	16
remains to be determined	16
the mechanism of action	16
did not result in	16
the number of donations	16
at the level of	16
the direct antiglobulin test	16
were not able to	16
rhd weak d type	16
respiratory syndrome coronavirus infection	16
play a crucial role	16
distribution of blood donors	16
the nature of the	16
on cd t cells	16
to the identification of	16
our objective was to	16
evaluate the effectiveness of	16
to that of the	16
taking into account the	16
the use of this	16
with a combination of	16
of the adaptive immune	16
of patients who were	16
should be considered in	16
i and ii molecules	15
a total of units	15
were not statistically significant	15
an effective treatment for	15
hla class ii molecules	15
drug reaction with eosinophilia	15
tested for the presence	15
dna was isolated from	15
the use of blood	15
a positive direct antiglobulin	15
occurred at a median	15
was used to compare	15
probability of overall survival	15
reaction with eosinophilia and	15
significantly higher than the	15
with no evidence of	15
a wide spectrum of	15
for patients with relapsed	15
mhc class i antigen	15
of hepatitis b virus	15
in of the cases	15
aim of the present	15
statistical analyses were performed	15
for hla class i	15
differences were observed in	15
activated cd t cells	15
total of patients with	15
in patients with hematologic	15
than half of the	15
in the atg group	15
higher in patients who	15
of memory t cells	15
without the use of	15
may be useful in	15
no statistical difference between	15
human leukocyte antigen class	15
patients who have been	15
the immune system and	15
were used in the	15
related morbidity and mortality	15
it was observed that	15
cumulative incidence of acute	15
was a trend towards	15
for blood and marrow	15
the association of the	15
patients received myeloablative conditioning	15
donors in order to	15
acute generalized exanthematous pustulosis	15
differences between the groups	15
assess the effect of	15
the clinical significance of	15
that cd t cells	15
this is due to	15
was lower in the	15
number of igg molecules	15
was more common in	15
in patients with covid	15
a t i o	15
evaluate the effect of	15
hla class ii alleles	15
study was to analyse	15
to mhc class i	15
the international society for	15
min at room temperature	15
study was conducted in	15
t cell epitopes in	15
consecutive patients who underwent	15
restricted cd t cell	15
are associated with a	15
have been implicated in	15
critical role in the	15
our results demonstrate that	15
reduced the incidence of	15
transfusion service in serbia	15
was carried out by	15
a subset of patients	15
study was to identify	15
patients with severe aplastic	15
be explained by the	15
all of them were	15
unrelated umbilical cord blood	15
was also associated with	15
to be positive for	15
blood stem cell transplant	15
a statistically significant difference	15
with relapsed or refractory	15
had a score of	15
it is associated with	15
in the range of	15
in case of a	15
the difference was not	15
heart and lung transplantation	15
the risk of bacterial	15
these findings indicate that	15
as shown in the	15
the median time for	15
associated with a reduced	15
x kg cd cells	15
in the czech republic	15
in allogeneic hematopoietic stem	15
we found a significant	15
with reduced intensity conditioning	15
the mean age was	15
was seen in the	15
found to have a	15
of the central nervous	15
cell source was bone	15
determine the frequency of	15
it is essential to	15
were tested for the	15
were divided into groups	15
is dependent on the	15
is characterized by a	15
response in patients with	15
the past few years	15
the intercept blood system	15
with mhc class i	15
study was conducted to	15
a significant increase of	15
for blood and blood	15
cell epitopes in the	15
found to be a	15
compared to the control	15
more than half of	15
the role of hla	15
the strength of the	15
risk factors for the	15
the risk of graft	15
outcomes of patients with	15
an increased frequency of	15
the use of high	15
in order to establish	15
patients who had received	15
it is unclear whether	15
in renal transplant recipients	15
of t cell clones	15
the patients who had	15
similar to those of	15
safety and immunogenicity of	15
blood samples were taken	15
results showed that the	15
of acute graft versus	15
with a range of	15
and mortality after allogeneic	15
chemotherapy followed by autologous	15
to the end of	15
have a role in	15
undergoing allogeneic stem cell	15
the group of hbsag	15
foxp regulatory t cells	15
during the first days	15
of rhd gamma globulin	15
in a total of	15
blood system for platelets	15
had no impact on	15
in group a and	15
cord blood stem cells	15
cells were treated with	15
we would like to	15
a myeloablative conditioning regimen	15
univariate and multivariate analysis	15
prevent the development of	15
of the blood supply	15
a high number of	15
both in vitro and	15
in the patients with	15
at a concentration of	15
activation and proliferation of	15
the electronic medical record	15
as one of the	15
higher in patients with	15
it is difficult to	15
the clinical outcome of	15
is the first report	15
the patients who were	15
of igg molecules per	15
a broad range of	15
compared to healthy controls	15
status at the time	15
risk of bacterial contamination	15
the present study we	15
on the role of	15
of human leukocyte antigen	15
in the last decade	15
be associated with the	15
neutrophil engraftment was days	15
b and t cell	15
than years of age	15
in the near future	15
a low level of	15
in the early s	15
results are summarized in	15
of bacterial contamination of	15
up to of patients	15
the median time between	15
cd t cell clones	15
in a population of	15
the volume of the	15
we show that the	15
s a and s	15
national blood transfusion institute	15
the immune system in	15
hemocue plasma low hb	15
in platelets stored at	15
t cell response in	15
the incidence of cmv	15
of t and b	15
in terms of the	15
a short period of	15
a review of the	15
incidence of cmv infection	15
and chronic gvhd were	15
on the incidence of	15
cell surface expression of	15
in order to assess	15
were performed in patients	15
significant difference was observed	14
may be responsible for	14
the university hospital of	14
associated with a decreased	14
safety of blood transfusion	14
difference was found between	14
through the activation of	14
the time of this	14
institute of hematology and	14
hla class i antigens	14
with the help of	14
evaluate the quality of	14
with a frequency of	14
influenza a h n	14
has been linked to	14
needed to confirm these	14
and red blood cell	14
he was treated with	14
dose of mg m	14
of patients with acute	14
in this cohort of	14
following hematopoietic stem cell	14
was associated with higher	14
in the detection of	14
median number of cd	14
the presence of antibodies	14
diagnosis and treatment of	14
to test the hypothesis	14
of the international society	14
in patients affected by	14
of acute gvhd was	14
here we report the	14
we have previously reported	14
the end of storage	14
in the past years	14
regarding the use of	14
patients older than years	14
median time of months	14
the effects of the	14
at increased risk for	14
processing and presentation of	14
was seen in patients	14
aim of this retrospective	14
very good partial response	14
the immune response in	14
for the patients with	14
and at the same	14
be a useful tool	14
and chronic gvhd in	14
hematopoietic stem cells transplantation	14
was calculated as the	14
plays a critical role	14
to play an important	14
significant morbidity and mortality	14
to study the effect	14
determine the effect of	14
whole blood and apheresis	14
as a positive control	14
the regulation of the	14
and hla class i	14
is not associated with	14
can be seen in	14
no significant effect on	14
screening and identification of	14
play a major role	14
between d and d	14
to declare p abstract	14
the human leukocyte antigen	14
study the effect of	14
our study is to	14
very low rate of	14
in hematopoietic stem cell	14
been shown to have	14
difference was not statistically	14
patients undergoing allogeneic hematopoietic	14
safe and effective in	14
is a lack of	14
the patient and the	14
for patients with acute	14
of a number of	14
test the hypothesis that	14
our data suggests that	14
was performed using a	14
could be explained by	14
the results show that	14
the results indicate that	14
only one of the	14
a cd t cell	14
in one of the	14
of the offending drug	14
of influenza a virus	14
in peripheral blood and	14
in the cases of	14
were performed using the	14
the incidence of agvhd	14
there is no evidence	14
of blood donors in	14
on the background of	14
reported in the literature	14
with a mean age	14
was considered to be	14
it is not known	14
the availability of blood	14
prophylaxis consisted of cyclosporine	14
are alive and well	14
it has been demonstrated	14
on the expression of	14
the limit of detection	14
a year old female	14
the cost of blood	14
cells from patients with	14
for severe aplastic anemia	14
gvhd was seen in	14
mg kg day for	14
to be an effective	14
survival at years was	14
specific t cells were	14
allogeneic peripheral blood stem	14
is used in the	14
a larger number of	14
a mean age of	14
than that of the	14
in peripheral blood of	14
bone marrow and peripheral	14
samples were taken from	14
patients were diagnosed with	14
were also positive for	14
of stem cells in	14
immune response in the	14
undergoing allogeneic hematopoietic stem	14
an important cause of	14
of the patients and	14
of cd low cd	14
overall survival in patients	14
was determined by the	14
the main causes of	14
to determine the prevalence	14
to evaluate the effect	14
the absence of any	14
role in the development	14
our data demonstrate that	14
was obtained from the	14
a total of blood	14
bacterial contamination of platelet	14
in v i m	14
the first days of	14
e and e proteins	14
high levels of cd	14
specific t cell response	14
even in the absence	14
detected by flow cytometry	14
the context of a	14
the limited number of	14
play a pivotal role	14
we have investigated the	14
be associated with a	14
the incidence of grade	14
of infused cd cells	14
reduce the number of	14
shown to be associated	14
and the absence of	14
is a safe and	14
were male and female	14
associated with increased mortality	14
there is no consensus	14
independent risk factor for	14
significantly higher than that	14
in blood and blood	14
from day to day	14
control of blood components	14
producing cd t cells	14
in about of cases	14
that there may be	14
the start of the	14
due to lack of	14
cells and b cells	14
under the same conditions	14
safety of the blood	14
marrow and peripheral blood	14
the presence of these	14
there is evidence that	14
median of days after	14
phase of the disease	14
results of this study	14
in our center from	14
days in the presence	14
data show that the	14
incidence of acute and	14
and a total of	14
for a variety of	14
due to disease progression	14
in the face of	14
short period of time	14
on day and day	14
for the patients who	14
the immune system is	14
on the same day	14
can be considered as	14
a single dose of	14
order to evaluate the	14
associated with the development	14
was found in of	14
because of the high	14
during the same period	14
after a median time	14
in the rate of	14
a period of years	14
patients with systemic lupus	14
were able to detect	14
for the selection of	14
patient died due to	14
of allogeneic hematopoietic cell	14
stem cell transplantation and	14
in blood donors in	14
been reported in the	14
a significant role in	14
the first year post	14
cd memory t cells	14
shown to be a	14
it is noteworthy that	14
were randomized to receive	14
may be used to	14
the natural history of	14
associated with the presence	14
all patients were treated	14
of at least one	14
treatment of multiple myeloma	14
to determine the effect	14
the mechanism by which	14
the time of analysis	14
there was no correlation	14
to the release of	14
caused by mutations in	14
in patients with systemic	13
nothing to declare o	13
is to investigate the	13
patients who received an	13
a leading cause of	13
specific t cells from	13
in patients with sle	13
as a part of	13
after the end of	13
the distribution of the	13
the structure of the	13
cd cell dose was	13
in the evaluation of	13
activation of cd t	13
spike protein of sars	13
the declaration of helsinki	13
highest binding affinity to	13
should be noted that	13
risk of graft failure	13
the protective effect of	13
hsct in children with	13
of t cells in	13
order to improve the	13
the weak d type	13
red blood cell antigens	13
as weak d type	13
similar results were obtained	13
cd t cell stimulatory	13
the in vitro quality	13
during the storage period	13
a patient with a	13
to determine the optimal	13
the blood bank and	13
the amino acid sequence	13
for patients with multiple	13
clinical use of blood	13
a retrospective study was	13
were independently associated with	13
these results show that	13
related or unrelated donors	13
was a significant difference	13
unrelated cord blood transplantation	13
the proportion of cd	13
la production de plaquettes	13
the red blood cell	13
by the immune system	13
with acute lymphoblastic leukemia	13
patients with severe covid	13
is an effective treatment	13
to the generation of	13
more common in the	13
blood stem cells were	13
the first months after	13
the results from the	13
the absence or presence	13
year os and pfs	13
the number of rbc	13
of nk cells in	13
assess the impact of	13
of the development of	13
the aim is to	13
herpes simplex virus glycoprotein	13
it is well known	13
cells were isolated from	13
in our cohort of	13
there is a lack	13
the identification of a	13
to a final concentration	13
there is a high	13
antibody screening and identification	13
related or unrelated donor	13
cells and cd cells	13
study was performed to	13
cd t cells can	13
the last five years	13
mhc class i alleles	13
was determined by flow	13
of the blood components	13
and the lack of	13
using a panel of	13
to the best of	13
were the most common	13
red blood cell transfusions	13
alive and disease free	13
and of the patients	13
was diagnosed in patients	13
in their ability to	13
high dose chemotherapy followed	13
initiation of the procedure	13
to be due to	13
significantly associated with the	13
were analyzed by flow	13
quality control of blood	13
as well as by	13
cd foxp regulatory t	13
well as for the	13
to the immune system	13
at last follow up	13
to assess the impact	13
to have the highest	13
absence or presence of	13
analysis was performed to	13
the pathogenesis of the	13
was supported by a	13
the ifitm ifitm double	13
the clinical impact of	13
especially in patients with	13
of one or more	13
patients developed acute gvhd	13
the quality and safety	13
was not statistically different	13
is related to the	13
was assessed using the	13
study is to analyze	13
and to evaluate the	13
cases have been reported	13
the formation of a	13
international society for heart	13
it should be noted	13
in t cell activation	13
the importance of the	13
a t cell receptor	13
there have been no	13
in at least one	13
the time of diagnosis	13
safety and quality of	13
the early phase of	13
higher than in the	13
and for patients with	13
resident memory t cells	13
the conditioning regimen for	13
used in the treatment	13
has not been reported	13
treatment option for patients	13
of class i and	13
in response to a	13
best of our knowledge	13
the frequency of hla	13
in a single center	13
the purpose of our	13
the risk of developing	13
effective use of blood	13
expression of hla class	13
of the role of	13
society of blood transfusion	13
total number of blood	13
did not find any	13
did not react with	13
associated with a significant	13
to the mhc i	13
play a critical role	13
working party of the	13
compared to those of	13
peptides derived from the	13
and the median age	13
ranged from to years	13
and was found to	13
in a blood donor	13
to neutrophil engraftment was	13
are required for the	13
has been demonstrated that	13
the serum of the	13
in those patients with	13
with full donor chimerism	13
determine the role of	13
in transfusion medicine is	13
treatment in patients with	13
it has also been	13
the efficacy of a	13
play important roles in	13
for cd t cells	13
of acute myeloid leukemia	13
evaluated by flow cytometry	13
and extensive chronic gvhd	13
a large panel of	13
the management of patients	13
febrile nonhemolytic transfusion reactions	13
the development of new	13
from matched unrelated donors	13
the implementation of a	13
we report on a	13
the first time in	13
and effective use of	13
umbilical cord blood stem	13
did not influence the	13
is responsible for the	13
for quality control of	13
we retrospectively analyzed patients	13
the median dose of	13
can be divided into	13
it remains to be	13
of hepatitis c virus	13
in patients who developed	13
amino acid sequence of	13
adverse events related to	13
the influence of the	13
sera from patients with	13
supported by a grant	13
can lead to a	13
the first year of	13
patients with haematological malignancies	13
cellular and humoral immune	13
the predictive value of	13
in this study the	13
class i mhc molecules	13
was measured by elisa	13
phase red cell adherence	13
the detection of antibodies	13
most common causes of	13
of the blood product	13
we have studied the	13
transfusion related acute lung	13
this study were to	13
mg m on day	13
have been identified in	13
the function of the	13
was not observed in	13
is caused by the	13
evaluate the safety and	13
minimize the risk of	13
acute gvhd occurred in	13
the d structure of	13
the sensitivity and specificity	13
in the following table	13
the best of our	13
to increase the number	13
has been found in	13
east respiratory syndrome coronavirus	13
with the capacity of	13
with the collaboration of	13
stem cell transplantation background	13
is safe and effective	13
characteristics of the patients	13
in all the cases	13
the development of an	13
the protein data bank	13
the spike protein of	13
in the ifitm ifitm	13
cd cells per kg	13
for cd t cell	13
to evaluate the safety	13
are alive and disease	13
our aim is to	13
resulted in a significant	13
peripheral blood progenitor cells	13
mice were immunized with	13
was seen in of	13
after the start of	13
as well as cd	13
and mhc class i	13
in active celiac disease	13
the relationship between the	13
can be found in	13
are considered to be	13
age at time of	13
a part of the	13
as well as other	13
in the level of	13
of cd cells infused	13
children and adolescents with	13
the results of our	13
important risk factor for	13
to evaluate the performance	13
for patients with aml	13
to evaluate the prevalence	13
the context of the	13
the possible role of	13
to play a role	13
mg kg on day	13
to the implementation of	13
characteristics are shown in	13
both class i and	13
survival and overall survival	13
patients with chronic gvhd	13
we have previously demonstrated	13
between january and june	13
of adult patients with	13
the distribution of blood	13
major cause of morbidity	13
the outcome of this	13
cd t cells that	13
was significantly increased in	13
national blood transfusion service	12
ex vivo expansion of	12
part of the conditioning	12
authors declare no competing	12
in of patients with	12
of cd b cd	12
without the need for	12
the impact of donor	12
in a timely manner	12
immunoglobulin g for intravenous	12
this study demonstrates that	12
a median time to	12
the monolisa hcv ag	12
in a group of	12
were used for the	12
of nkg d ligands	12
analysis showed that the	12
is likely to be	12
during the development of	12
cd and cd cd	12
the importance of this	12
method was used to	12
of cmv infection in	12
of lung transplant recipients	12
we observed an increase	12
reduced the risk of	12
patients at high risk	12
were divided into two	12
in all patients with	12
associated with higher risk	12
to the formation of	12
and platelet engraftment were	12
spleen and lymph nodes	12
associated with development of	12
was significantly better in	12
in order to minimize	12
cells in the absence	12
a trend for a	12
we suggest that the	12
and the availability of	12
for a long time	12
we have identified a	12
the risk of gvhd	12
out of the patients	12
was not due to	12
not differ significantly between	12
in mice immunized with	12
in patients with advanced	12
with regard to the	12
chronic gvhd occurred in	12
been implicated in the	12
to the general population	12
the department of transfusion	12
haematopoietic stem cell transplant	12
in the caucasian population	12
through the use of	12
may be important in	12
of the host immune	12
g for intravenous use	12
cd t cell subsets	12
cumulative incidence of agvhd	12
during the first months	12
mg kg on days	12
were predicted to be	12
from the time of	12
i and type ii	12
difference between the two	12
the gold standard for	12
and to determine the	12
in both groups of	12
this is the largest	12
and event free survival	12
may play an important	12
male and female donors	12
median dose of cd	12
patients received bone marrow	12
in patients transplanted from	12
new york blood center	12
are listed in table	12
in the transfusion chain	12
of the expression of	12
tumor necrosis factor alpha	12
cd t cell populations	12
cd t cells specific	12
patients were in complete	12
t cell recognition of	12
were observed in patients	12
and were included in	12
is required for the	12
genomic dna was isolated	12
of patients who had	12
d d and hla	12
between and were included	12
disease control and prevention	12
performed to determine the	12
who did not develop	12
reactive cd t cells	12
wt wt for the	12
transplant related mortality was	12
granulocyte colony stimulating factor	12
with higher risk of	12
binding affinity of the	12
hospitals with the capacity	12
with one of the	12
regimens were used in	12
patients with active disease	12
from july to december	12
in the area of	12
use of blood products	12
mhc class i interaction	12
the number of cases	12
cd t cell memory	12
years of age and	12
t cell proliferation and	12
the role of cd	12
the h d mutation	12
high levels of il	12
within the first months	12
evaluate the efficacy of	12
of the global blood	12
not appear to be	12
of extensive chronic gvhd	12
an increased susceptibility to	12
the age of the	12
production of blood products	12
centre for transfusion medicine	12
immune response to the	12
were carried out in	12
class i or ii	12
free survival and overall	12
at time of transplantation	12
under the control of	12
kg day for days	12
the effect of a	12
in order to make	12
in patients with active	12
by the expression of	12
the course of infection	12
all but one patient	12
median cd cell dose	12
plays a key role	12
in the russian federation	12
play a significant role	12
hydrogen bonds with the	12
mother bag by culture	12
was found that the	12
the hla class i	12
study was supported by	12
the procleix ultrio assay	12
confirmed the presence of	12
stored for up to	12
of neutrophil and platelet	12
bone marrow transplantation unit	12
the number of the	12
also found to be	12
free and overall survival	12
we present a case	12
contribute to the development	12
in an enzymatic medium	12
the two groups were	12
play a key role	12
a significant cause of	12
the abo blood group	12
and to study the	12
for min at room	12
intercept blood system for	12
the efficacy of this	12
to the emergence of	12
with enzyme treated red	12
the host immune system	12
in combination with other	12
affinity to the mhc	12
to minimize the risk	12
the innate and adaptive	12
the evaluation of the	12
the patient had no	12
total of units of	12
the percentage of patients	12
and the impact of	12
follow up was months	12
and distribution of blood	12
of the fact that	12
patients at risk for	12
all patients had received	12
acute gvhd was observed	12
and risk factors for	12
is to analyze the	12
our understanding of the	12
in patients with relapsed	12
to assess the effect	12
showed no significant difference	12
cytokines such as il	12
due to the risk	12
prospective studies are needed	12
with high risk of	12
the detection of anti	12
the absolute number of	12
phase ii clinical trial	12
retrospective study was to	12
to the intensive care	12
are one of the	12
the absence of cd	12
were transfused more often	12
treated with high dose	12
a higher proportion of	12
this cohort of patients	12
in order to achieve	12
d present in the	12
were shown to be	12
number of patients with	12
as compared to patients	12
hbv infection in the	12
measured by flow cytometry	12
for allogeneic stem cell	12
the treatment of choice	12
human immunoglobulin g for	12
been shown to increase	12
test was used for	12
cells were detected in	12
is the first study	12
statistically significant differences between	12
of a patient with	12
in platelet additive solution	12
lilrb d d and	12
of the lack of	12
type i and type	12
the first report of	12
high dose chemotherapy and	12
there was also a	12
is a need for	12
assessed by flow cytometry	12
we sought to determine	12
in the clinical setting	12
and an increase in	12
of t cell proliferation	12
this version posted april	12
a total of pts	12
extensive chronic gvhd was	12
of blood products in	12
the small number of	12
with an increase of	12
at the dose of	12
and the control group	12
an increasing number of	12
pure red cell aplasia	12
study is to compare	12
our results showed that	12
in our blood centre	12
was more frequent in	12
led to a significant	12
is well known that	12
and chronic gvhd was	12
the ebmt risk score	12
differences were observed between	12
the most common indication	12
predicted to bind to	12
retrospective analysis of the	12
study was approved by	12
were not associated with	12
reduced intensity conditioning regimens	12
will be able to	12
were collected before and	12
prevention and treatment of	12
the origin of the	12
makes it possible to	12
in the final product	12
samples from blood donors	12